Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background Migraine is a complex, neurobiological disorder usually presenting as a unilateral, moderate to severe headache accompanied by sensory disturbances. Migraine prevalence has risen globally, affecting 14% of individuals and 16% of students and carries many negative impacts in both cohorts. With no recent meta‐analysis of global migraine prevalence or associated factors in students, this systematic review and meta‐analysis were conducted. Databases and data treatment The review was registered with PROSPERO (CRD42020167927). Electronic databases (n = 12) were searched for cross‐sectional studies (1988 to August 2021, IHS criteria). Ninety‐two articles were meta‐analysed and 103 were narratively reviewed. The risk of bias was assessed using an established tool. Results The risk of bias ranged from low to moderate. Migraine pooled prevalence (R‐Studio) was demonstrated at 19% (95% CI, 16%–22%, p < 0.001, I^2 98%): females 23% (95% CI, 19%–27%, p < 0.001), males 12% (95% CI, 9%–15%, p < 0.001). Gender (p < 0.0001), geographical region (p = 0.01), migraine types (p = 0.0002) and prevalence timeframes (p = 0.02) may be influencing the substantial heterogeneity. Migraine triggers were primarily behavioural and environmental and treatments were predominantly pharmaceutical. Impacts ranged from academic performance impairment to psychological co‐morbidities. Conclusions This study offers the most comprehensive overview of migraine prevalence and associated factors in university students. Migraine prevalence in university students has increased and has many negative effects. Enhancing migraine recognition and management at university may have positive implications for an improved educational experience, as well as for the burden migraine currently incurs, both in university and beyond. Significance This global systematic review and meta‐analysis of 92 studies and narrative review of 103 studies provide the most comprehensive synthesis to date of migraine prevalence and associated factors in university students. Pooled prevalence has increased to 19%. The significant heterogeneity demonstrated is influenced by gender, geographical region, migraine type and prevalence timeframes. Students manage migraines primarily with pharmaceuticals. Further studies conducted in low and middle‐income countries, following headache protocols and reporting frequency of treatment‐seeking and medication usage are warranted.
Background Migraine is a complex, neurobiological disorder usually presenting as a unilateral, moderate to severe headache accompanied by sensory disturbances. Migraine prevalence has risen globally, affecting 14% of individuals and 16% of students and carries many negative impacts in both cohorts. With no recent meta‐analysis of global migraine prevalence or associated factors in students, this systematic review and meta‐analysis were conducted. Databases and data treatment The review was registered with PROSPERO (CRD42020167927). Electronic databases (n = 12) were searched for cross‐sectional studies (1988 to August 2021, IHS criteria). Ninety‐two articles were meta‐analysed and 103 were narratively reviewed. The risk of bias was assessed using an established tool. Results The risk of bias ranged from low to moderate. Migraine pooled prevalence (R‐Studio) was demonstrated at 19% (95% CI, 16%–22%, p < 0.001, I^2 98%): females 23% (95% CI, 19%–27%, p < 0.001), males 12% (95% CI, 9%–15%, p < 0.001). Gender (p < 0.0001), geographical region (p = 0.01), migraine types (p = 0.0002) and prevalence timeframes (p = 0.02) may be influencing the substantial heterogeneity. Migraine triggers were primarily behavioural and environmental and treatments were predominantly pharmaceutical. Impacts ranged from academic performance impairment to psychological co‐morbidities. Conclusions This study offers the most comprehensive overview of migraine prevalence and associated factors in university students. Migraine prevalence in university students has increased and has many negative effects. Enhancing migraine recognition and management at university may have positive implications for an improved educational experience, as well as for the burden migraine currently incurs, both in university and beyond. Significance This global systematic review and meta‐analysis of 92 studies and narrative review of 103 studies provide the most comprehensive synthesis to date of migraine prevalence and associated factors in university students. Pooled prevalence has increased to 19%. The significant heterogeneity demonstrated is influenced by gender, geographical region, migraine type and prevalence timeframes. Students manage migraines primarily with pharmaceuticals. Further studies conducted in low and middle‐income countries, following headache protocols and reporting frequency of treatment‐seeking and medication usage are warranted.
Background and objectives: Migraine is commonly associated with psychiatric comorbidities, especially in developed countries. Herein, we investigated the burden of comorbid depression and associated factors among patients with migraine (PWM) in low resource setting. Methods: This was a hospital-based cross-sectional study of PWM conducted at Federal Neuropsychiatric Hospital (FNPH) Maiduguri. Consenting participants with known migraine on follow up visits were consecutively recruited. Depressive symptoms were ascertained using the Beck’s Depression Inventory (BDI), while the impact of migraine was assessed using the Headache Impact Test-6 (HIT-6) questionnaire. Multivariate regression analysis was done to determine independent factors associated with depression among migraineurs. Results: The study constituted 165 PWM. Participants were predominantly females (72.1%) and the mean age of the participants was 29.6 ± 9.6, with age range of 17-55 years. About 46% of migraineurs had mild to no impact, while 37.6% of the participants had severe headache impact. Increased migraine impact was associated with: female gender (P<0.037), migraine with aura (P<0.001), chronic migraine (P<0.001), photophobia (P<0.001), and poor utilization of prophylactic drugs (P<0.014). Forty-five percent of the participants had varying degrees of depression among which the majority (43.4%) had mild, 19.6% moderate, 14.3% severe, and 1.79% had extreme comorbid depression. Factors associated with depression were: female gender, migraine with aura, chronic migraine, photophobia, utilization of migraine prophylactic drugs, and impactful migraine all with P≤0.001. We found a strong positive linear relationship between headache impact and depression (r=0.76, P<0.001). On multivariate analysis, males had 76.3% less likelihood of being depressed [95% confidence interval (CI) of (0.068-0.828)] compared with their female counterparts. Increasing migraine impact was also significantly (P<0.05) associated with depression. Those with no impact, mild impact, and substantial impact of migraine had 97.4%, 97.1%, and 88.4% less likelihood of being depressed compared to those with severe impact with 95% CI (0.004-0.159), (0.006-0.148)], and (0.029-0.463)] respectively. Conclusion: We found a high prevalence of comorbid depression among PWM in our environment with inadequate utilization of treatment contributing to both the burden of migraine and depression.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.